Premier Alternatives

OrbitalRx

Winston-Salem, NC · Founded 2017 · Privately Held (backing)

Developer of drug shortage management software designed to assist the hospital pharmacy team in improving medication shortages. OrbitalRx is based in Winston-Salem, NC and was founded in 2017. It was valued at $25.2 million at its seed round in Oct 2025, the last priced event on record. It has raised $7.4 million across 6 recorded rounds; the latest was a $1.2 million seed round in Aug 2025.

PMV mark · valuation
$25.2M
Oct 2026
Priced at
its seed round
Oct 2025
Total raised
$7.4M
Last round
Seed Round
Aug 2025

OrbitalRx key facts

as of Oct 2026
  • Developer of drug shortage management software designed to assist the hospital pharmacy team in improving medication shortages.
  • OrbitalRx is valued at approximately $25.2M as of Oct 2026, set at its seed round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $7.4M across 6 recorded rounds; the latest was Seed Round ($1.2M) in Aug 2025.
  • Notable investors include Hatteras Venture Partners, Triangle Angel Partners, Alerion Ventures, Boston Millennia Partners, Excelerate Health Ventures — 7 tracked in total.
  • OrbitalRx has filed 8 Form Ds with the SEC since 2018, most recently Mar 2025 ($959K sold to 18 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$25.2M

Valued at $25.2M at its seed round, Oct 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of OrbitalRx with a free account
  • ·Watch OrbitalRx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OrbitalRx funding rounds

6 rounds
Aug 2025Seed Round$1.2MSEC filing▮
Jan 2025Seed Round$959KSEC filing▮
May 2024Seed Round$856KSEC filing▮
May 2023Seed Round$1.4MSEC filing▮
Feb 2020Debt$733KSEC filing▮
Full funding history →

OrbitalRx valuation

OrbitalRx was valued at $25.2 million at its seed round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has OrbitalRx raised?

OrbitalRx has raised $7.4 million across 6 recorded rounds since 2018. The largest was a $958,932 seed round in Jan 2025; the most recent was a $1.2 million seed round in Aug 2025.

OrbitalRx has filed 8 Form Ds with the SEC since 2018, most recently in Mar 2025 ($958,932 sold to 18 investors).

OrbitalRx investors

7 investors are on record for OrbitalRx, including Hatteras Venture Partners, Triangle Angel Partners, Alerion Ventures and Boston Millennia Partners. The seed round in Aug 2025 drew 22 investors.

About OrbitalRx

Developer of drug shortage management software designed to assist the hospital pharmacy team in improving medication shortages. The company's software facilitates users in visualizing, optimizing, and customizing a portfolio of pharmacy automation systems regardless of vendor, enabling healthcare professionals to manage the workflow and data challenges of ongoing medication shortages.

Sector
Healthcare
HQ
Winston-Salem, NC, United States
Founded
2017
Employees
17
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.